Letter: assessment of safety and efficacy of mesalazine in Indian patients with ulcerative colitis
- PMID: 23738791
- DOI: 10.1111/apt.12336
Letter: assessment of safety and efficacy of mesalazine in Indian patients with ulcerative colitis
Comment on
-
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.Aliment Pharmacol Ther. 2013 Apr;37(8):767-75. doi: 10.1111/apt.12266. Epub 2013 Mar 4. Aliment Pharmacol Ther. 2013. PMID: 23451806 Clinical Trial.